Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

SELL
$28.82 - $77.35 $3.22 Million - $8.64 Million
-111,668 Reduced 82.95%
22,959 $926,000
Q2 2022

Jul 13, 2022

BUY
$28.82 - $77.35 $3.03 Million - $8.14 Million
105,268 Added 358.55%
134,627 $16.7 Million
Q1 2022

Apr 11, 2022

SELL
$48.25 - $100.49 $613,981 - $1.28 Million
-12,725 Reduced 30.24%
29,359 $1.95 Million
Q4 2021

Jan 21, 2022

SELL
$88.71 - $120.43 $5.44 Million - $7.39 Million
-61,323 Reduced 59.3%
42,084 $4.21 Million
Q3 2021

Oct 08, 2021

SELL
$98.77 - $132.17 $3.08 Million - $4.13 Million
-31,220 Reduced 23.19%
103,407 $12.9 Million
Q2 2021

Jul 16, 2021

BUY
$109.77 - $165.68 $3.78 Million - $5.7 Million
34,422 Added 34.35%
134,627 $16.7 Million
Q1 2021

Apr 12, 2021

BUY
$127.04 - $179.1 $665,435 - $938,125
5,238 Added 5.52%
100,205 $15.3 Million
Q4 2020

Feb 08, 2021

BUY
$99.96 - $135.93 $646,741 - $879,467
6,470 Added 7.31%
94,967 $12.2 Million
Q3 2020

Oct 13, 2020

BUY
$80.32 - $111.8 $421,278 - $586,391
5,245 Added 6.3%
88,497 $9.89 Million
Q2 2020

Jul 09, 2020

BUY
$60.49 - $97.5 $840,931 - $1.36 Million
13,902 Added 20.05%
83,252 $6.75 Million
Q1 2020

May 08, 2020

BUY
$59.04 - $88.81 $197,488 - $297,069
3,345 Added 5.07%
69,350 $4.83 Million
Q4 2019

Feb 13, 2020

BUY
$59.49 - $82.78 $248,668 - $346,020
4,180 Added 6.76%
66,005 $5.16 Million
Q3 2019

Nov 20, 2019

BUY
$62.59 - $110.3 $588,971 - $1.04 Million
9,410 Added 17.95%
61,825 $3.95 Million
Q2 2019

Jul 24, 2019

BUY
$63.94 - $91.11 $815,554 - $1.16 Million
12,755 Added 32.16%
52,415 $4.53 Million
Q1 2019

May 14, 2019

BUY
$34.3 - $97.98 $1.36 Million - $3.89 Million
39,660 New
39,660 $3.04 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.75B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.